Medtronic Updates Interim CFO Compensation

Ticker: MDT · Form: 8-K/A · Filed: 2024-08-16T00:00:00.000Z

Sentiment: neutral

Topics: executive-compensation, amendment, cfo

Related Tickers: MDT

TL;DR

Medtronic amended its filing to detail new pay for its interim CFO.

AI Summary

Medtronic plc filed an 8-K/A on August 16, 2024, to update a prior disclosure regarding compensation arrangements for its interim Chief Financial Officer (CFO). This amendment follows the Compensation Committee's approval of new compensation terms for the interim CFO, effective June 21, 2024.

Why It Matters

This filing clarifies the compensation structure for Medtronic's interim CFO, providing transparency on executive pay arrangements. Investors can review these details to understand executive compensation policies.

Risk Assessment

Risk Level: low — The filing is an amendment to a previous disclosure regarding executive compensation, which typically carries low risk unless it reveals significant unexpected changes.

Key Players & Entities

Medtronic plc (company) — Filer of the 8-K/A
Interim Chief Financial Officer (person) — Subject of the compensation arrangement update
Compensation Committee (company) — Approved the new compensation arrangements
June 21, 2024 (date) — Effective date of the compensation arrangements
August 16, 2024 (date) — Filing date of the 8-K/A

FAQ

What is the purpose of this 8-K/A filing?

The purpose of this 8-K/A filing is to update a prior disclosure regarding new compensation arrangements approved by the Compensation Committee for Medtronic's interim Chief Financial Officer.

When were the new compensation arrangements for the interim CFO approved?

The new compensation arrangements for the interim CFO were approved by the Compensation Committee.

What is the effective date of these compensation arrangements?

The compensation arrangements are effective as of June 21, 2024.

Who is the subject of the compensation update?

The subject of the compensation update is Medtronic's interim Chief Financial Officer.

What type of filing is this, and when was it filed?

This is an 8-K/A filing, which was filed on August 16, 2024.

From the Filing

0001613103-24-000133.txt : 20240816 0001613103-24-000133.hdr.sgml : 20240816 20240816070142 ACCESSION NUMBER: 0001613103-24-000133 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240621 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240816 DATE AS OF CHANGE: 20240816 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medtronic plc CENTRAL INDEX KEY: 0001613103 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 FISCAL YEAR END: 0425 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36820 FILM NUMBER: 241214112 BUSINESS ADDRESS: STREET 1: BUILDING TWO PARKMORE BUSINESS PARK WEST CITY: GALWAY STATE: L2 ZIP: 1 BUSINESS PHONE: 01135314381700 MAIL ADDRESS: STREET 1: BUILDING TWO PARKMORE BUSINESS PARK WEST CITY: GALWAY STATE: L2 ZIP: 1 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Ltd DATE OF NAME CHANGE: 20150112 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Holdings Ltd DATE OF NAME CHANGE: 20140711 FORMER COMPANY: FORMER CONFORMED NAME: Kalani I Ltd DATE OF NAME CHANGE: 20140709 8-K/A 1 mdt-20240621.htm 8-K/A mdt-20240621 0001613103 D02 XH02 true Updating prior disclosure as a result of compensation committee approval of new compensation arrangements for our interim CFO. H91 VY19 0001613103 2024-06-21 2024-06-21 0001613103 dei:FormerAddressMember 2024-06-21 2024-06-21 0001613103 us-gaap:CommonStockMember 2024-06-21 2024-06-21 0001613103 mdt:A0.250SeniorNotesDue2025Member 2024-06-21 2024-06-21 0001613103 mdt:A0.000SeniorNotesDue2025Member 2024-06-21 2024-06-21 0001613103 mdt:A2.625SeniorNotesDue2025Member 2024-06-21 2024-06-21 0001613103 mdt:A1.125SeniorNotesDue2027Member 2024-06-21 2024-06-21 0001613103 mdt:A0.375SeniorNotesDue2028Member 2024-06-21 2024-06-21 0001613103 mdt:A3.000SeniorNotesDue2028Member 2024-06-21 2024-06-21 0001613103 mdt:A3.650SeniorNotesDue2029Member 2024-06-21 2024-06-21 0001613103 mdt:A1.625SeniorNotesDue2031Member 2024-06-21 2024-06-21 0001613103 mdt:A1.000SeniorNotesDue2031Member 2024-06-21 2024-06-21 0001613103 mdt:A3.125SeniorNotesDue2031Member 2024-06-21 2024-06-21 0001613103 mdt:A0.750SeniorNotesDue2032Member 2024-06-21 2024-06-21 0001613103 mdt:A3.375SeniorNotesDue2034Member 2024-06-21 2024-06-21 0001613103 mdt:A3.875SeniorNotesDue2036Member 2024-06-21 2024-06-21 0001613103 mdt:A2.250SeniorNotesDue2039Member 2024-06-21 2024-06-21 0001613103 mdt:A1.500SeniorNotesDue2039Member 2024-06-21 2024-06-21 0001613103 mdt:A1.375SeniorNotesDue2040Member 2024-06-21 2024-06-21 0001613103 mdt:A4.150SeniorNotesDue2043Member 2024-06-21 2024-06-21 0001613103 mdt:A1.750SeniorNotesDue2049Member 2024-06-21 2024-06-21 0001613103 mdt:A1.625SeniorNotesDue2050Member 2024-06-21 2024-06-21 0001613103 mdt:A4.150SeniorNotesDue2053Member 2024-06-21 2024-06-21 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   _____________________________  FORM 8-K/A Amendment No. 1   _____________________________  CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 21, 2024   _____________________________  Medtronic plc (Exact name of Registrant as Specified in its Charter)    _____________________________    Ireland   1-36820   98-1183488 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.) Building Two Parkmore Business Park West Galway, Ireland (Address of principal executive offices) (Zip Code) + 353 1 438-1700 (Registrant’s telephone number, including area code) 20 On Hatch , Lower Hatch Street , Dublin 2 , Ireland Former name or former address, if changed since last report Chec